{"id":432900,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2020-02-13] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T09:08:43.485000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/multiple-additions-2020-02-13.html?wbdisable=true","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions February 13, 2020 Our file number: 20-102134-993 The purpose of this Notice of Amendment is to notify about the additions of gemtuzumab ozogamacin, gilteritinib, icosapent ethyl, tafamidis, trifarotine and upadacitinib to…","rawSnapshotUrl":"/api/snapshots/raw/432900","browseUrl":"https://replay.healtharchive.ca/job-6/20260102090843/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/multiple-additions-2020-02-13.html?wbdisable=true#ha_snapshot=432900","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}